Piramal Pharma Solutions Enhances HPAPI Manufacturing with Korsch X3 Installation at Morpeth Facility

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA...

March 27, 2026 | Friday | News
SK pharmteco and Prozomix Partner to Accelerate Sustainable Biocatalysis in Small-Molecule Manufacturing

 SK pharmteco, a leading global contract development and manufacturing organization (CDMO), and Prozomix, a pioneer in enzyme discovery and diversity,...

March 26, 2026 | Thursday | News
Gilead to Acquire Ouro Medicines in $2.17B Deal to Expand Autoimmune T Cell Engager Portfolio

Gilead Sciences, Inc. (Nasdaq: GILD) announced  it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology...

March 25, 2026 | Wednesday | News
Cytiva and SR-TIGET Launch EU’s First Danaher Beacon to Advance Scalable Genomic Medicine

New “Danaher Beacon,” first in the European Union, aims to accelerate translation, scalability, and reliability across cell and gene therap...

March 25, 2026 | Wednesday | News
Eli Lilly’s Retatrutide Delivers Up to 2.0% A1C Reduction and 16.8% Weight Loss in Phase 3 TRANSCEND-T2D-1

For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1 Participants taking retatrut...

March 23, 2026 | Monday | News
AstraZeneca, Secaro, and ERM Launch Clean Heat Program to Accelerate Supply Chain Decarbonization

 While companies make decarbonization progress elsewhere, heat has been considered too challenging to progress. -      ...

March 18, 2026 | Wednesday | News
Alessa Reports Positive Phase 1 Data for Enolen Localized Enzalutamide Implants in Early Prostate Cancer

First study to demonstrate safe and selective administration of sustained and localized delivery of enzalutamide -Alessa Therapeutics (“...

March 17, 2026 | Tuesday | News
Sarepta Initiates ENDEAVOR Cohort 8 to Evaluate Sirolimus Safety Strategy with ELEVIDYS in Non-Ambulatory Duchenne Patients

- Approximately 25 non-ambulatory participants will receive sirolimus as part of the regimen in Cohort 8 of the ENDEAVOR study - The enhanced immunosu...

March 17, 2026 | Tuesday | News
IFF Expands Health & Biosciences Capabilities in Latin America with New Fermentation Hub and Innovation Lab

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production an...

March 12, 2026 | Thursday | News
CMIC Co., Ltd. Partners with Bluenote to Deploy Agentic AI Across Clinical Development

CMIC Co., Ltd., a contract research organization (CRO) jointly owned by Blackstone and CMIC HOLDINGS Co. Ltd.,  announced a strategic partnership with...

March 11, 2026 | Wednesday | News
Neuland Laboratories to Launch Commercial-Scale Peptide Manufacturing Facility in 2026

 Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with ...

March 11, 2026 | Wednesday | News
Halozyme Therapeutics, Inc and Johnson & Johnson Secure FDA Approval for TECVAYLI® Plus DARZALEX FASPRO® in RRMM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) announced that Johnson & Johnson has received approval from the U.S. Food and Drug Administrati...

March 09, 2026 | Monday | News
Eli Lilly and Company Partners with WHO Foundation to Strengthen Global Obesity Care

The WHO Foundation announced a collaboration with Eli Lilly and Company that aims to support the WHO Foundation's global efforts to assess and strengthen...

March 09, 2026 | Monday | News
Forge Biologics to Manufacture PRF’s SamPro-2 Gene Therapy for IND Advancement

The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gi...

March 05, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close